CAS: 1338824-20-6
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | 4(1H)-Quinazolinone,2-[3-[(2,6-dimethylphenoxy)methyl]-4-methoxyphenyl]-2,3-dihydro-3-(3-pyridinylmethyl)- REF: IN-DA01XAN6CAS: 1338824-20-6 | 98% | A consultar | Vie 18 Oct 24 |
 | NCGC00229600 REF: TM-T12192CAS: 1338824-20-6 | 99.27% | 62,00 €~2.759,00 € | Vie 20 Dic 24 |
4(1H)-Quinazolinone,2-[3-[(2,6-dimethylphenoxy)methyl]-4-methoxyphenyl]-2,3-dihydro-3-(3-pyridinylmethyl)-
CAS:1338824-20-6
Fórmula:
C30H29N3O3
Pureza:
98%
Peso molecular:
479.5696
Ref: IN-DA01XAN6
| 1mg | 147,00 € | ||
| 5mg | 578,00 € | ||
| 10mg | 612,00 € | ||
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Viernes 18 de Octubre de 2024
NCGC00229600
CAS:1338824-20-6
NCGC00229600: Allosteric inverse TSHR agonist; blocks TSH and antibody TSHR activation; for Graves' disease research.
Fórmula:
C30H29N3O3
Pureza:
99.27%
Forma y color:
Solid
Peso molecular:
479.57
Ref: TM-T12192
| 1mg | 62,00 € | ||
| 1ml | 148,00 € | ||
| 5mg | 141,00 € | ||
| 10mg | 205,00 € | ||
| 25mg | 360,00 € | ||
| 50mg | 542,00 € | ||
| 100mg | 819,00 € | ||
| 200mg | 1.082,00 € |
Entrega estimada en Estados Unidos, el Viernes 20 de Diciembre de 2024
